• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缓释口服吗啡给药后癌症疼痛患者脑脊液和血浆中的吗啡及吗啡代谢物浓度

Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration.

作者信息

Wolff Tomas, Samuelsson Håkan, Hedner Thomas

机构信息

Pain Sections, Department of Anaesthesia, Central Hospitals, Skövde and Borås, Sweden Department of Clinical Pharmacology, Sahlgrenska University Hospital, Göteborg, Sweden.

出版信息

Pain. 1995 Aug;62(2):147-154. doi: 10.1016/0304-3959(94)00268-J.

DOI:10.1016/0304-3959(94)00268-J
PMID:8545139
Abstract

In 34 cancer patients treated with chronic slow-release oral morphine, plasma and cerebrospinal fluid (CSF) minimum steady-state concentrations of morphine (M), morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G) were determined by high-performance liquid chromatography (HPLC). Both plasma and CSF morphine, M3G and M6G, concentrations were linearly related to dose of morphine. At steady state, the mean +/- SEM CSF/plasma morphine concentration ratio was 0.8 +/- 0.1. In plasma and CSF, the mean steady-state concentrations of M3G and M6G substantially exceeded those of morphine where the mean CSF M/M3G/M6G ratio was 1:47:5 (weight basis), 1:34:4 (molar basis) and the mean plasma ratio was M/M3G/M6G 1:150:23 (weight basis), 1:109:17 (molar basis). The mean M3G and M6G concentrations in CSF at steady state were 15-18% of those found in plasma. Pain relief, evaluated by a visual analogue scale (VAS), did not correlate with the CSF M3G concentrations or with the M3G/M ratio. Since CSF M6G concentrations were high, M6G could, however, contribute to pain relief. We conclude that after oral administration of slow-release morphine, there is a significant passage of the morphine glucuronide metabolites to the CSF and that the M3G and M6G metabolites in CSF are in the concentration range where they may have an influence on analgesia.

摘要

在34例接受慢性缓释口服吗啡治疗的癌症患者中,采用高效液相色谱法(HPLC)测定了血浆和脑脊液(CSF)中吗啡(M)、吗啡-3-葡萄糖醛酸苷(M3G)和吗啡-6-葡萄糖醛酸苷(M6G)的最低稳态浓度。血浆和脑脊液中的吗啡、M3G和M6G浓度均与吗啡剂量呈线性相关。稳态时,平均±标准误脑脊液/血浆吗啡浓度比为0.8±0.1。在血浆和脑脊液中,M3G和M6G的平均稳态浓度大大超过吗啡的浓度,其中脑脊液中M/M3G/M6G平均比值为1:47:5(重量比)、1:34:4(摩尔比),血浆平均比值为M/M3G/M6G 1:150:23(重量比)、1:109:17(摩尔比)。脑脊液中稳态时M3G和M6G的平均浓度为血浆中浓度的15 - 18%。通过视觉模拟评分法(VAS)评估的疼痛缓解与脑脊液中M3G浓度或M3G/M比值无关。然而,由于脑脊液中M6G浓度较高,M6G可能有助于缓解疼痛。我们得出结论,口服缓释吗啡后,吗啡葡萄糖醛酸代谢产物可大量进入脑脊液,且脑脊液中的M3G和M6G代谢产物浓度范围可能对镇痛有影响。

相似文献

1
Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration.缓释口服吗啡给药后癌症疼痛患者脑脊液和血浆中的吗啡及吗啡代谢物浓度
Pain. 1995 Aug;62(2):147-154. doi: 10.1016/0304-3959(94)00268-J.
2
Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients.癌症疼痛患者持续皮下注射吗啡期间脑脊液和血浆中吗啡及吗啡代谢物的浓度
Pain. 1996 Dec;68(2-3):209-16. doi: 10.1016/s0304-3959(96)03102-8.
3
CSF and plasma concentrations of morphine and morphine glucuronides in cancer patients receiving epidural morphine.接受硬膜外吗啡治疗的癌症患者脑脊液和血浆中吗啡及吗啡葡萄糖醛酸苷的浓度。
Pain. 1993 Feb;52(2):179-185. doi: 10.1016/0304-3959(93)90129-D.
4
Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.癌症相关疼痛患者血浆中吗啡、吗啡 - 6 - 葡萄糖醛酸苷和吗啡 - 3 - 葡萄糖醛酸苷的浓度及其与镇痛和副作用的关系。
Palliat Med. 2003 Mar;17(2):185-90. doi: 10.1191/0269216303pm658oa.
5
Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain.对吗啡耐受疼痛患者给予吗啡后血清和脑脊液中吗啡、吗啡-6-葡萄糖醛酸苷和吗啡-3-葡萄糖醛酸苷的浓度。
Pain. 1994 Feb;56(2):145-149. doi: 10.1016/0304-3959(94)90088-4.
6
Morphine metabolites.吗啡代谢物。
Acta Anaesthesiol Scand. 1997 Jan;41(1 Pt 2):116-22. doi: 10.1111/j.1399-6576.1997.tb04625.x.
7
The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories.给药途径的影响:口服缓释吗啡与硫酸吗啡栓剂稳态的比较研究。
Ther Drug Monit. 1999 Apr;21(2):208-14. doi: 10.1097/00007691-199904000-00011.
8
Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients.常规临床药物监测期间对吗啡、M6G和M3G血清浓度的影响:对300例成年癌症患者的前瞻性调查
Acta Anaesthesiol Scand. 2003 Jul;47(6):725-31. doi: 10.1034/j.1399-6576.2003.00138.x.
9
Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine.口服吗啡长期给药期间血浆和脑脊液中吗啡及吗啡 - 葡萄糖醛酸苷的浓度
Br J Clin Pharmacol. 1994 Sep;38(3):271-3. doi: 10.1111/j.1365-2125.1994.tb04352.x.
10
Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine.癌症患者开始口服吗啡:有效的血清吗啡浓度及吗啡-6-葡萄糖醛酸对吗啡产生的镇痛作用的贡献。
Eur J Clin Pharmacol. 2000 Jan;55(10):713-9. doi: 10.1007/s002280050003.

引用本文的文献

1
Morphine-3-Glucuronide, Physiology and Behavior.吗啡-3-葡萄糖醛酸苷,生理学与行为学
Front Mol Neurosci. 2022 May 12;15:882443. doi: 10.3389/fnmol.2022.882443. eCollection 2022.
2
Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome.体外研究显示阿片类药物可抑制人源 5-HT 和去甲肾上腺素转运体:与临床报告的血清素综合征相关联。
Br J Pharmacol. 2018 Feb;175(3):532-543. doi: 10.1111/bph.14105. Epub 2018 Jan 6.
3
Glucuronidation: driving factors and their impact on glucuronide disposition.
葡萄糖醛酸化:驱动因素及其对葡萄糖醛酸苷处置的影响。
Drug Metab Rev. 2017 May;49(2):105-138. doi: 10.1080/03602532.2017.1293682. Epub 2017 May 22.
4
Dual modulation of the T-cell receptor-activated signal transduction pathway by morphine in human T lymphocytes.吗啡对人 T 淋巴细胞 T 细胞受体激活信号转导通路的双重调节作用。
J Anesth. 2013 Feb;27(1):80-7. doi: 10.1007/s00540-012-1472-9. Epub 2012 Aug 30.
5
Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain.比较两种用于癌症疼痛的美沙酮转换策略时的阿片类药物血清浓度。
Eur J Clin Pharmacol. 2012 Aug;68(8):1147-56. doi: 10.1007/s00228-012-1228-3. Epub 2012 Feb 29.
6
Oral-parenteral conversion factor for morphine in palliative cancer care: a prospective randomized crossover pilot study.姑息性癌症护理中吗啡的口服-胃肠外转换因子:一项前瞻性随机交叉试点研究。
Pain Res Treat. 2011;2011:504034. doi: 10.1155/2011/504034. Epub 2011 Feb 15.
7
Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics.阿片酊灵活给药用于阿片类药物戒断管理:药代动力学与药效学
Br J Clin Pharmacol. 2008 Nov;66(5):640-7. doi: 10.1111/j.1365-2125.2008.03277.x.
8
Serum and cerebrospinal fluid morphine pharmacokinetics after single doses of intravenous and intramuscular morphine after hip replacement surgery.髋关节置换术后单次静脉注射和肌肉注射吗啡后的血清及脑脊液吗啡药代动力学
Eur J Clin Pharmacol. 2007 Sep;63(9):837-42. doi: 10.1007/s00228-007-0329-x. Epub 2007 Jul 10.
9
Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids.(R)-和(S)-美沙酮及结构相关阿片类药物对吗啡体外生成M3G和M6G的差异抑制作用。
Br J Clin Pharmacol. 2006 Mar;61(3):326-35. doi: 10.1111/j.1365-2125.2005.02573.x.
10
Morphine-6-glucuronide: an analgesic of the future?吗啡-6-葡萄糖醛酸:未来的镇痛药?
Clin Pharmacokinet. 2001;40(7):485-99. doi: 10.2165/00003088-200140070-00001.